These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8066002)

  • 1. Ependymomas in children: histologic and DNA-flow cytometric study.
    Reyes-Mugica M; Chou PM; Myint MM; Ridaura-Sanz C; Gonzalez-Crussi F; Tomita T
    Pediatr Pathol; 1994; 14(3):453-66. PubMed ID: 8066002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric DNA analysis of pediatric intracranial ependymomas.
    Kotylo PK; Robertson PB; Fineberg NS; Azzarelli B; Jakacki R
    Arch Pathol Lab Med; 1997 Dec; 121(12):1255-8. PubMed ID: 9431314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.
    Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R
    Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.
    Prayson RA
    Ann Diagn Pathol; 1999 Feb; 3(1):11-8. PubMed ID: 9990108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy and nuclear morphometry in adult intracranial ependymomas.
    Onguru O; Ulutin C; Celasun B; Gunhan O
    Clin Neuropathol; 2003; 22(6):266-72. PubMed ID: 14672504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index.
    Asai A; Hoshino T; Edwards MS; Davis RL
    Childs Nerv Syst; 1992 Aug; 8(5):273-8. PubMed ID: 1394266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic prognostic factors in ependymoma.
    Schiffer D; Chiò A; Giordana MT; Migheli A; Palma L; Pollo B; Soffietti R; Tribolo A
    Childs Nerv Syst; 1991 Aug; 7(4):177-82. PubMed ID: 1933913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ependymomas: MIB-1 proliferation index and survival.
    Ritter AM; Hess KR; McLendon RE; Langford LA
    J Neurooncol; 1998 Oct; 40(1):51-7. PubMed ID: 9874186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ependymomas: a clinical and pathologic study. Part I. Biologic features.
    Ilgren EB; Stiller CA; Hughes JT; Silberman D; Steckel N; Kaye A
    Clin Neuropathol; 1984; 3(3):113-21. PubMed ID: 6205805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow-cytometric DNA analysis of intracranial tumors in children.
    Habermehl P; Knuf M; Schwarz M; Bohl J; Bartels U; Gutjahr P; Hohenfellner K
    Pathol Res Pract; 2004; 200(3):197-202. PubMed ID: 15200271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-flow fluorescence--cytometry of ependymomas. Report on ten surgically removed tumours.
    Spaar FW; Blech M; Ahyai A
    Acta Neuropathol; 1986; 69(1-2):153-60. PubMed ID: 3962592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant behavior of myxopapillary ependymoma. Report of three cases.
    Davis C; Barnard RO
    J Neurosurg; 1985 Jun; 62(6):925-9. PubMed ID: 3998846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma.
    Ho DM; Hsu CY; Wong TT; Chiang H
    J Neurooncol; 2001 Aug; 54(1):77-85. PubMed ID: 11763426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytophotometric investigations of the nuclear DNA content in ependymomas and plexuspapillomas (author's transl)].
    Müller W; Brämisch R; Afra D; Schwenzfeger A
    Acta Neuropathol; 1977 Aug; 39(3):255-9. PubMed ID: 906808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in intracranial ependymomas in children.
    Figarella-Branger D; Civatte M; Bouvier-Labit C; Gouvernet J; Gambarelli D; Gentet JC; Lena G; Choux M; Pellissier JF
    J Neurosurg; 2000 Oct; 93(4):605-13. PubMed ID: 11014538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The growth potential of ependymomas with varying grades of malignancy measured by the Ki-67 labelling index and mitotic index.
    Schröder R; Ploner C; Ernestus RI
    Neurosurg Rev; 1993; 16(2):145-50. PubMed ID: 8345908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic subependymoma: a clinicopathological and flow cytometric study.
    Lombardi D; Scheithauer BW; Meyer FB; Forbes GS; Shaw EG; Gibney DJ; Katzmann JA
    J Neurosurg; 1991 Oct; 75(4):583-8. PubMed ID: 1885976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study.
    Shepherd CW; Scheithauer BW; Gomez MR; Altermatt HJ; Katzmann JA
    Neurosurgery; 1991 Jun; 28(6):864-8. PubMed ID: 2067610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ependymomas. A clinical survey.
    Barone BM; Elvidge AR
    J Neurosurg; 1970 Oct; 33(4):428-38. PubMed ID: 5471932
    [No Abstract]   [Full Text] [Related]  

  • 20. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
    Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
    J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.